A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Public ClinicalTrials.gov record NCT07184944. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Phase 3, Maintenance Study to Evaluate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Study identification
- NCT ID
- NCT07184944
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Sanofi
- Industry
- Enrollment
- 751 participants
Conditions and interventions
Conditions
Interventions
- Duvakitug Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 16 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 21, 2026
- Primary completion
- Aug 12, 2029
- Completion
- Mar 19, 2034
- Last update posted
- May 13, 2026
2026 – 2034
United States locations
- U.S. sites
- 14
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Peak Gastroenterology Associates - Colorado Springs-Site Number: 8400039 | Colorado Springs | Colorado | 80907 | Recruiting |
| Clinical Research of Osceola-Site Number: 8400013 | Kissimmee | Florida | 34741 | Recruiting |
| Bioresearch Partner-Kendale Lakes-Site Number: 8400053 | Miami | Florida | 33175 | Recruiting |
| NMC Research LLC-Site Number: 8400033 | Tampa | Florida | 33607 | Recruiting |
| GI Alliance - Baton Rouge-Site Number: 8400129 | Baton Rouge | Louisiana | 70809 | Recruiting |
| Gateway Gastroenterology-Site Number: 8400097 | St Louis | Missouri | 63141 | Recruiting |
| NYU Langone Health-Site Number: 8400091 | New York | New York | 10016 | Recruiting |
| New York Gastroenterology Associates-Site Number: 8400009 | New York | New York | 10075 | Recruiting |
| Cross Creek Medical Clinic-Site Number: 8400057 | Fayetteville | North Carolina | 28304 | Recruiting |
| Ohio Gastroenterology Group Inc.-Site Number: 8400006 | Columbus | Ohio | 43202 | Recruiting |
| OSU Wexner Medical Center-Site Number: 8400077 | Columbus | Ohio | 43210 | Recruiting |
| Gastroenterology Research of San Antonio LLC-Site Number: 8400054 | San Antonio | Texas | 78229 | Recruiting |
| Tyler Research Institute LLC-Site Number: 8400095 | Tyler | Texas | 75701 | Recruiting |
| Gastroenterology Associates of Western Michigan-Site Number: 8400060 | Wyoming | Wyoming | 49519 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07184944, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 13, 2026 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07184944 live on ClinicalTrials.gov.